CHARLOTTE, N.C., June 8, 2020 /PRNewswire-PRWeb/ -- Leading medical technology company, MedShift, announces their third major release of their IoT connected devices platform. This platform provides an end-to-end solution for device manufacturers, integrating their purpose-built credit card-sized computer boards, with encrypted private cellular SIM capabilities, into any medical device line up. This integration allows the MedShift platform to interact with and receive rich data from device operating systems in a variety of formats. Another significant announcement for this updated platform is that it has been recognized and accepted by the FDA.
MedShift CEO, Brian Phillips, has this to say about the latest platform improvements, "We are always looking for ways to provide straightforward, innovative solutions for our providers and manufacturers. With this new version of our IoT platform, we are able to offer a cost-effective, FDA accepted, highly customizable way to connect manufacturer devices with ease, helping them to create full visibility across the device portfolio."
This matured version of the device connectivity platform is HIPPA compliant, PCI compliant, and built with the medical industry's unique needs as its focus. The purpose-built state of the art hardware and software combine to lend full flexibility in feature set and function for any manufacturer and any device.
Adam Walsh, MedShift's Director of Engineering, believes that "this platform has the potential to elevate device performance and function. While we updated and added many different features to the new version, it is very exciting to have the FDA's recognition and acceptance of this third version."
The platform includes many innovative features, some of which include remote monitoring of procedures and procedure delivery settings, pay per procedure enablement, on-device credit card processing, remote diagnostics, and remote upgrades. These features are convenient for generating diverse revenue streams from the device, as well as maintaining and operating them to their full capabilities. Another noteworthy function is that only encrypted traffic to and from the IoT hardware and device is accepted. This additional security, as well as its many features, further advances devices' accessibility and usage.
Both manufacturer and practice can benefit from this innovative platform. It can be deployed retroactively or installed during the manufacturing of a device, either internally or externally. With the MedShift IoT platform, manufacturers can connect their devices to the secure MedShift cloud and garner information directly from them, supplying them with an immediate, robust amount of information. The MedShift IoT platform is available in more than 165 countries and can be integrated into any device from any manufacturer.
About MedShift
MedShift, founded in 2015 in Charlotte, NC delivers a platform as a service to both medical device manufacturers as well as individual medical practices. Foundationally MedShift enables access to the latest devices and technology to remain competitive and attract new business. MedShift has partnered with over 250 providers in North America, Australia, and New Zealand to give practices the latest in cutting-edge treatment modalities, services, and systems.
MedShift is disrupting the traditional aesthetic device market by offering permanent placement, holistic subscription services for surgeons, physicians and their business. MedShift's broad portfolio of services for practices includes a portfolio of 24 leading aesthetic medical devices from nine manufacturers, an aesthetic eCommerce and subscription platform, in-house communications and marketing services, and inbound lead generation. For manufacturers Medshift delivers a highly secure IoT platform consisting of both hardware and software assets allowing for real time visibility, remote management, and big data modeling of entire medical device lineups. MedShift adds value across the manufacturer and provider spectrum and continues to empower robust integration with the leading brands and doctors in the industry.
SOURCE MedShift
Share this article